[ad_1]
Friday, September 14, 2018
Jonathan Sackler – his family is about to take advantage of the new antidote. PHOTO: Sacred Heart
The billionaire family, whose company is being sued by states and cities across the country for their role in creating the opioid crisis, is now launching a new patented antidote for the drug called "Heroin in a pill" ".
Oxycodone and the new drug will be produced side by side at the Rhodes Technologies plant – a subsidiary of Purdue Pharma – in Coventry, Rhode Island.
The idea that the Sacklers, who hold an estimated net worth of $ 14 billion coming primarily from Purdue Pharma 's property, will benefit from the launch of a new drug that will combat the impact of the drug. oxycontin, angered many actors. medications and reverse the death toll related to opioid abuse.
E-mails addressed to Purdue Pharma's communications office were not answered.
Nan Goldin, a photographer and opioid crisis activist in a statement to artnet News, said, "This is reprehensible and denotes a lack of moral conscience. Perhaps they can then patent a funeral home. The statement goes on to condemn Purdue, its owners – the billionaire Sackler family who has close ties to the art world – and other manufacturers for taking advantage of the necessary anti-opioid treatments requiring that They are made available free of charge.
"It's diabolical to deliberately take advantage of the sick and then sell them a 'cure' for their illness," said Goldin and two other prominent activists.
The Rhodes Technologies plant in Coventry will produce both Oxy and the new antidote.
US Patent and Trademakr Office information shows the Rhodes Technologies plant in Coventry, RI is granted the patent for the new drug. Rhodes Technologies is the subsidiary of Purdue Pharma belonging to the Sackler family.
The calls and e-mails addressed to Rhodes Technologies and its affiliate marketing company Rhodes Pharma have not received a response.
Purdue Pharma has been the subject of a number of presentations, including a major survey conducted by the New Yorker titled "The Family Who Constructed an Empire of Pain".
"The ruthless commercialization of analgesics by the Sackler dynasty has generated billions of dollars and millions of drug addicts," wrote Patrick Radden Keefe for this publication.
The Centers for Disease Control estimates that the number of deaths from overdoses reached a record 72,000 in 2017, an increase of 10% over 2016.
Rhode Island Trial
The state of Rhode Island is part of a group of states pursuing Purdue. The Rhode Island complaint alleges in part a 108-page filing: "In 2015, Purdue raised approximately $ 2.4 billion in revenue, almost all of which came from opioids. Since its launch in 1996, OxyContin alone has generated $ 35 billion in sales.
"In Rhode Island, the age-adjusted overdose rate in 2015 of 28.2 per 100,000 population ranks fifth in the country. From 2014 to 2015, Rhode Island experienced a 24% change in one year of overdose deaths, the third highest change in America. The rate of deaths from synthetic opioids such as fentanyl is ranked third nationally in 2015. From 2011 to 2016, Rhode Island also recorded a 303% increase in overdose deaths, "states the trial.
And the State of Rhode Island alleges that "Purdue not only commercialized opioids for chronic pain problems, but also targeted primary care physicians (as well as nurse practitioners and physician assistants) most likely to see patients with chronic pain and less likely to have the training and experience necessary to assess both the marketing of the accused and the pain conditions of the patients. "
The patent was awarded in January.
The new antidote
According to documents filed with the US Patent Office, the buprenorphine tablet for drug substitution therapy is attributed to the Coventry plant.
Abstract
The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine, the instant-releasing dosage form of buprenorphine by oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution treatment in drug dependent humans.
Enjoy this post? Share it with others.
[ad_2]
Source link
